Genomic imprinting and cancer

Experimental Cell Research

Volumn 248, Issue 1, 1999, Pages 18-24

  Jirtle, Randy L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; GENE EXPRESSION; GENETIC LINKAGE; GENOME IMPRINTING; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE; PENETRANCE; PRIORITY JOURNAL; SHORT SURVEY; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0033541448     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4453     Document Type: Article

References (83)

1. Brockdorff N., Duthie S. M. X chromosome inactivation and the Xist gene. Cell Mol. Life Sci. 54:1998;104-112.
2. Barlow D. P. Gametic imprinting in mammals. Science. 270:1995;1610-1613.
3. Bartolomei M. S., Tilghman S. M. Genomic imprinting in mammals. Annu. Rev. Genet. 31:1997;493-525.
4. Constancia M., Pickard B., Kelsey G., Reik W. Imprinting mechanisms. Genome Res. 8:1998;881-900.
5. McGrath J., Solter D. Completion of mouse embryogenesis requires both the maternal and paternal genomes. Cell. 37:1984;179-183.
6. Surani M. A., Barton S. C., Norris M. L. Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature. 308:1984;548-550.
7. Kajii T., Ohama K. Androgenetic origin of hydatidiform mole. Nature. 268:1977;633-634.
8. Ohama K., Nomura K., Okamoto E., Fukuda Y., Ihara T., Fujiwara A. Origin of immature teratoma of the ovary. Am. J. Obstet. Gynecol. 152:1985;896-900.
9. Falls J. G., Pulford D. J., Wylie A. A., Jirtle R. L. Genomic imprinting: implications for human disease. Am. J. Pathol. 154:1999;635-647.
10. DeChiara T. M., Robertson E. J., Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell. 64:1991;849-859.
11. Vu T. H., Hoffman A. R. Promoter-specific imprinting of the human insulin-like growth factor-II gene. Nature. 371:1994;714-717.
12. Barlow D. P., Stšger R., Herrmann B. G., Saito K., Schweifer N. The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature. 349:1991;84-87.
13. Wang Z. Q., Fung M. R., Barlow D. P., Wagner E. F. Regulation of embryonic growth and lysosomal targeting by the imprintedIgf2/Mpr. Nature. 372:1994;464-467.
14. Kornfeld S. Structure and function of the mannose 6-phosphate/insulin-like growth factor II receptors. Annu. Rev. Biochem. 61:1992;307-330.
15. Czech M. P., Lewis R. E., Corvera S. Multifunctional glycoprotein receptors for insulin and the insulin-like growth factors. Ciba Found. Symp. 145:1989;27-41.
16. Morrione A., Valentinis B., Xu S.-Q., Yumet G., Louvi A., Efstratiadis A., Baserga R. Insulin-like growth factor II stimulates cell proliferation through the insulin receptor. Proc. Natl. Acad. Sci. USA. 94:1997;3777-3782.
17. Haig D., Graham C. Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell. 64:1991;1045-1046.
18. Hurst L. D., McVean G. T. Growth effects of uniparental disomies and the conflict theory of genomic imprinting. Trends Genet. 13:1997;436-443.
19. Sun F. L., Dean W. L., Kelsey G., Allen N. D., Reik W. Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome. Nature. 389:1997;809-815.
20. Nezer C., Moreau L., Brouwers B., Coppieters W., Detilleux J., Hanset R., Karim L., Kvasz A., Leroy P., Georges M. An imprinted QTL with major effect on muscle mass and fat deposition maps to the IGF2 locus in pigs. Nat. Genet. 21:1999;155-156.
21. Jeon J. T., Carlborg O., Tornsten A., Giuffa E., Amarger V., Chardon P., Andersson-Eklund L., Andersson K., Hansson I., Lundstrom K., Andersson L. A paternally expressed QTL affecting skeletal and cardiac muscle mass in pigs maps to the IGF2 locus. Nat. Genet. 21:1999;157-158.
22. Lalande M. Parental imprinting and human disease. Annu. Rev. Genet. 30:1996;173-195.
23. Kobayashi S., Kohda T., Miyoshi N., Kuroiwa Y., Aisaka K., Tsutsumi O., Kaneko-Ishino T., Ishino F. Human PEG1/MEST, an imprinted gene on chromosome 7. Hum. Mol. Genet. 6:1997;781-786.
24. Lefebvre L., Viville S., Barton S. C., Ishino F., Keverne E. B., Surani M. A. Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene Mest. Nat. Genet. 20:1998;163-169.
25. Chorney M. J., Chorney K., Seese N., Owen M. J., Daniels J., McGuffin P., Thompson L. A., Detterman D. K., Benbow C., Lubinski D., Eley T., Plomin R. A quantitative trait locus associated with cognitive ability in children. Psych. Sci. 9:1998;159-166.
26. Cook E. H. Jr., Lindgren V., Leventhal B. L., Courchesne R., Lincoln A., Shulman C., Lord C., Courchesne E. Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am. J. Hum. Genet. 60:1997;928-934.
27. Grigoroiu-Serbanescu M., Wickramaratne P. J., Hodge S. E., Milea S., Mihailescu R. Genetic anticipation and imprinting in bipolar I illness. Br. J. Psychiatry. 170:1997;162-166.
28. Kato T., Winokur G., Coryell W., Keller M. B., Endicott J., Rice J. Parent-of-origin effect in transmission of bipolar disorder. Am. J. Med. Genet. 67:1996;546-550.
29. Ohara K., Xu H. D., Mori N., Suzuki Y., Xu D. S., Wang Z. C. Anticipation and imprinting in schizophrenia. Biol. Psychiatry. 42:1997;760-766.
30. Morison I. M., Reeve A. E. A catalogue of imprinted genes and parent-of-origin effects in humans and animals. Hum. Mol. Genet. 7:1998;1599-1609.
31. Pulford D. J., Falls J. G., Killian J. K., Jirtle R. L. Polymorphisms, genomic imprinting and cancer susceptibility. Mutat. Res. 436:1999;59-67.
32. Hendrich B. D., Huntington F. W. Epigenetic regulation of gene expression: the effect of altered chromatin structure from yeast to mammals. Hum. Mol. Genet. 4:1995;1765-1777.
33. Feil R., Kelsey G. Genomic imprinting: A chromatin connection. Am. J. Hum. Gent. 61:1997;1213-1219.
34. Ogawa O., Eccles M. R., Szeto J., McNoe L. A., Yun K., Maw M. A., Smith P. J., Reeve A. E. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature. 362:1993;749-751.
35. Rainier S., Johnson L. A., Dobry C. J., Ping A. J., Grundy P. E., Feinberg A. P. Relaxation of imprinted genes in human cancer. Nature. 362:1993;747-749.
36. Steenman M. J. C., Rainier S., Dobry C. J., Grundy P., Horon I. L., Feinberg A. P. Loss of imprinting ofIGF2H19. Nat. Genet. 7:1994;433-439.
37. Bates P., Fisher R., Ward A., Richardson L., Hill D. J., Graham C. F. Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II). Br. J. Cancer. 72:1995;1189-1193.
38. Rogler C. E., Yang D., Rossetti L., Donohoe J., Alt E., Chang C. J., Rosenfeld R., Neely K., Hintz R. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J. Biol. Chem. 269:1994;13779-13784.
39. Hao Y., Crenshaw T., Moulton T., Newcomb E., Tycko B. Tumor-suppressor activity of H19. Nature. 365:1993;764-767.
40. Webber A. L., Ingram R. S., Levorse J. M., Tilghman S. M. Location of enhancers is essential for the imprinting of H19 and Igf2 genes. Nature. 391:1998;711-715.
41. Leighton P. A., Ingram R. S., Eggenschwiler J., Efstratiatis A., Tilghman S. M. Disruption of imprinting caused by deletion of theH19. Nature. 375:1995;34-39.
42. Okamoto K., Morison I. M., Taniguchi T., Reeve A. E. Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis. Proc. Natl. Acad. Sci. USA. 94:1997;5367-5371.
43. Huff V. Wilms tumor genetics. Am. J. Med. Genet. 79:1998;260-267.
44. Jinno Y., Yun K., Nishiwaki K., Kubota T., Ogawa O., Reeve A. E., Niikawa N. Mosaic and polymorphic imprinting of the WT1 gene in humans. Nat. Genet. 6:1994;305-309.
45. Nishiwaki K., Niikawa N., Ishikawa M. Polymorphic and tissue-specific imprinting of the human Wilms tumor gene, WT1. Jpn. J. Hum. Genet. 42:1997;205-211.
46. Mitsuya K., Sui H., Meguro M., Kugoh H., Jinno Y., Niikawa N., Oshimura M. Paternal expression of WT1 in human fibroblasts and lymphocytes. Hum. Mol. Genet. 6:1997;2243-2246.
47. KIP2. Hum. Mol. Genet. 5:1996;783-788.
48. Hatada I., Mukai T. Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nat. Genet. 11:1995;204-206.
49. Hatada I., Ohashi H., Fukushima Y., Kaneko Y., Inoue M., Komoto Y., Okada A., Ohishi S., Nabetani A., Morisaki H., Nakayama M., Niikawa N., Mukai T. An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome. Nat. Genet. 14:1996;171-173.
50. O'Keefe D., Dao D., Zhao L., Sanderson R., Warburton D., Weiss L., Anyane-Yeboa K., Tycko B. Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors. Am. J. Hum. Genet. 61:1997;295-303.
51. Kondo M., Matsuoka S., Uchida K., Osada H., Nagatake M., Takagi K., Harper J. W., Takahashi T., Elledge S. J. Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5. Oncogene. 12:1996;1365-1368.
52. Taniguchi T., Okamoto K., Reeve A. E. Human p57(KIP2) defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumour. Oncogene. 14:1997;1201-1206.
53. Yu Y., Xu F., Peng H., Fang X., Zhao S., Li Y., Cuevas B., Kuo W. L., Gray J. W., Siciliano M., Mills G. B., Bast R. C. Jr. NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc. Natl. Acad. Sci. USA. 96:1999;214-219.
54. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J. C., Valent A., Minty A., Chalon P., Lelias J. M., Dumont X., Ferrara P., McKeon F., Caput D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 90:1997;809-819.
55. Jost C. A., Marin M. C., Kaelin W. G. Jr. p73 is a human p53-related protein that can induce apoptosis. Nature. 389:1997;191-194.
56. Nomoto S., Haruki N., Kondo M., Konishi H., Takahashi T. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res. 58:1998;1380-1383.
57. Kovalev S., Marchenko N., Swendeman S., LaQuaglia M., Moll U. M. Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines. Cell Growth Differ. 9:1998;897-903.
58. Nimura Y., Mihara M., Ichimiya S., Sakiyama S., Seki N., Ohira M., Nomura N., Fujimori M., Adachi W., Amano J., He M., Ping Y. M., Nakagawara A. p73, a gene related to p53, is not mutated in esophageal carcinomas. Int. J. Cancer. 78:1998;437-440.
59. Mai M., Huang H., Reed C., Qian C., Smith J. S., Alderete B., Jenkins R., Smith D. I., Liu W. Genomic organization and mutation analysis of p73 in oligodendrogliomas with chromosome 1 p-arm deletions. Genomics. 51:1998;359-363.
60. Sunahara M., Ichimiya S., Nimura Y., Takada N., Sakiyama S., Sato Y., Todo S., Adachi W., Amano J., Nakagawara A. Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas. Int. J. Oncol. 13:1998;319-323.
61. Kroiss M. M., Bosserhoff A. K., Vogt T., Buettner R., Bogenrieder T., Landthaler M., Stolz W. Loss of expression or mutations in the p73 tumour suppressor gene are not involved in the pathogenesis of malignant melanomas. Melanoma Res. 8:1998;504-509.
62. Tsao H., Zhang X., Majewski P., Haluska F. G. Mutational and expression analysis of the p73 gene in melanoma cell lines. Cancer Res. 59:1999;172-174.
63. Mai M., Qian C., Yokomizo A., Tindall D. J., Bostwick D., Polychronakos C., Smith D. I., Liu W. Loss of imprinting and allele switching of p73 in renal cell carcinoma. Oncogene. 17:1998;1739-1741.
64. Mai M., Yokomizo A., Qian C., Yang P., Tindall D. J., Smith D. I., Liu W. Activation of p73 silent allele in lung cancer. Cancer Res. 58:1998;2347-2349.
65. De Souza A. T., Hankins G. R., Washington M. K., Fine R. L., Orton T. C., Jirtle R. L. Frequent loss of heterozygosity on 6q at the mannose 6- phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene. 10:1995;1725-1729.
66. De Souza A. T., Hankins G. R., Washington M. K., Orton T. C., Jirtle R. L. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat. Genet. 11:1995;447-449.
67. Hankins G. R., De Souza A. T., Bentley R. C., Patel M. R., Marks J. R., Iglehart J. D., Jirtle R. L. M6P/IGF2. Oncogene. 12:1996;2003-2009.
68. Yamada T., De Souza A. T., Finkelstein S., Jirtle R. L. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc. Natl. Acad. Sci. USA. 94:1997;10351-10355.
69. Piao Z., Choi Y., Park C., Lee W. J., Park J. H., Kim H. Deletion of the M6P/IGF2r gene in primary hepatocellular carcinoma. Cancer Lett. 120:1997;39-43.
70. Mills J. J., Falls J. G., De Souza A. T., Jirtle R. L. ImprintedM6p/Igf2. Oncogene. 16:1998;2797-2802.
71. Souza R. F., Appel R., Yin J., Wang S., Smolinski K. N., Abraham J. M., Zou T.-T., Shi Y.-Q., Lei J., Cottrell J., Cymes K., Biden K., Simms L., Leggett B., Lynch P. M., Frazier M., Powell S. M., Harpaz N., Sugimura H., Young J., Meltzer S. J. The insulin-like growth factor II receptor gene is a target of microsatellite instability in human gastrointestinal tumours. Nat. Genet. 14:1996;255-257.
72. Ouyang H., Shiwaku H. O., Hagiwara H., Miura K., Abe T., Kato Y., Ohtani H., Shiiba K., Souza R. F., Meltzer S. J., Horii A. Theinsulin-like growth factor II receptor. Cancer Res. 57:1997;1851-1854.
73. Leung S. Y., Chan T. L., Chung L. P., Chan A. S., Fan Y. W., Hung K. N., Kwong W. K., Ho J. W., Yuen S. T. Microsatellite instability and mutation of DNA mismatch repair genes in gliomas. Am. J. Pathol. 153:1998;1181-1188.
74. Kalscheuer V. M., Mariman E. C., Schepens M. T., Rehder H., Ropers H.-H. The insulin-like growth factor type-2 receptor gene is imprinted in the mouse but not in humans. Nat. Genet. 5:1993;74-78.
75. Ogawa O., McNoe L. A., Eccles M. R., Morison I. M., Reeve A. E. Human insulin-like growth factor type I and type II receptors are not imprinted. Hum. Mol. Genet. 2:1993;2163-2165.
76. Xu Y., Goodyer C. G., Deal C., Polychronakos C. Functional polymorphism in the parental imprinting of the human IGF2R gene. Biochem. Biophys. Res. Commun. 197:1993;747-754.
77. Xu Y. Q., Grundy P., Polychronakos C. Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor. Oncogene. 14:1997;1041-1046.
78. Stšger R., Kubicka P., Liu C. G., Kafri T., Razin A., Cedar H., Barlow D. P. Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal. Cell. 73:1993;61-71.
79. Wutz A., Smrzka O. W., Schweifer N., Schellander K., Wagner E. F., Barlow D. P. Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature. 389:1997;745-749.
80. Birger Y., Shemer R., Perk J., Razin A. The imprinting box of the mouse Igf2r gene. Nature. 397:1999;84-88.
81. Smrzka O. W., Fae I., Stöger R., Kurzbauer R., Fischer G. F., Henn T., Weith A., Barlow D. P. Conservation of a maternal-specific methylation signal at the human IGF2R locus. Hum. Mol. Genet. 4:1995;1945-1952.
82. Riesewijk A. M., Schepens M. T., Welch T. R., Van den Berg-Loonen E. M., Mariman E. M., Ropers H. H., Kalscheuer V. M. Maternal-specific methylation of the humanIGF2R. Genomics. 31:1996;158-166.
83. Chappell S. A., Walsh T., Walker R. A., Shaw J. A. Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas. Br. J. Cancer. 76:1997;1558-1561.